3D Bioprinting of Vascularized Tissues for in vitro and in vivo Applications
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
With a limited supply of organ donors and available organs for transplantation, the aim of tissue engineering with three-dimensional (3D) bioprinting technology is to construct fully functional and viable tissue and organ replacements for various clinical applications. 3D bioprinting allows for the customization of complex tissue architecture with numerous combinations of materials and printing methods to build different tissue types, and eventually fully functional replacement organs. The main challenge of maintaining 3D printed tissue viability is the inclusion of complex vascular networks for nutrient transport and waste disposal. Rapid development and discoveries in recent years have taken huge strides toward perfecting the incorporation of vascular networks in 3D printed tissue and organs. In this review, we will discuss the latest advancements in fabricating vascularized tissue and organs including novel strategies and materials, and their applications. Our discussion will begin with the exploration of printing vasculature, progress through the current statuses of bioprinting tissue/organoids from bone to muscles to organs, and conclude with relevant applications for in vitro models and drug testing. We will also explore and discuss the current limitations of vascularized tissue engineering and some of the promising future directions this technology may bring.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070 · cited 2×
“When examining the printed tissue’s physiological needs, we see that the limit of diffusion for O2 in tissue is generally accepted to be limited to 100–200 μm (Krogh, 1919; Carmeliet and Jain, 2000; Jain et al., 2005).”
Background3D bioprinting of collagen to rebuild components of the human heart
Lee, A., Hudson, A. R., Shiwarski, D. J., Tashman, J. W., Hinton, T. J., Yerneni, S., Bliley, J. M., Campbell, P. G., & Feinberg, A. W. (2019) · Science · doi:10.1126/science.aav9051 · Cited by 1,782
Trefts, E., Gannon, M., & Wasserman, D. H. (2017) · Current Biology · doi:10.1016/j.cub.2017.09.019 · Cited by 1,452
Advancing biomaterials of human origin for tissue engineering
Chen, F.-M., & Liu, X. (2016) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2015.02.004 · Cited by 1,158 · cited 1×
“However, comparative studies on the efficacies of the different constructs in terms of vascular nutrient transport and tissue viability are lacking (Chen and Liu, 2016).”
Background3D printing of functional biomaterials for tissue engineering
Zhu, W., Ma, X., Gou, M., Mei, D., Zhang, K., & Chen, S. (2016) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2016.03.014 · Cited by 822 · cited 4×
“…scaffolds for 3D bioprinting also determines tissue integrity, interconnectivity of different components within the organ, and temporal release of growth factors and bioactive substances for proper tissue development or repair (Zhu et al., 2016; Zhang et al., 2017; Gungor-Ozkerim et al., 2018).”
BackgroundMethodInfluentialBioprinting for vascular and vascularized tissue biofabrication
Datta, P., Ayan, B., & Ozbolat, I. T. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.01.035 · Cited by 431
Bioengineered in vitro models of thrombosis: methods and techniques
Zhang, Y. S., Oklu, R., & Albadawi, H. (2017) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2017.08.08 · Cited by 23 · cited 1×
“…scaffolds for 3D bioprinting also determines tissue integrity, interconnectivity of different components within the organ, and temporal release of growth factors and bioactive substances for proper tissue development or repair (Zhu et al., 2016; Zhang et al., 2017; Gungor-Ozkerim et al., 2018).”
Background
Cited by
Farjaminejad, S., Farjaminejad, R., Hasani, M., Garcia-Godoy, F., Abdouss, M., Marya, A., Harsoputranto, A., & Jamilian, A. (2024) · Polymers · doi:10.3390/polym16233303 · Cited by 158
“These combined approaches ensure better nutrient delivery and improve the success of bone regeneration [60].”
Revolutionizing Disease Modeling: The Emergence of Organoids in Cellular Systems
Silva-Pedrosa, R., Salgado, A. J., & Ferreira, P. E. (2023) · Cells · doi:10.3390/cells12060930 · Cited by 84
Metadata
- Authors
- Chen, E. P., Toksoy, Z., Davis, B. A., & Geibel, J. P.
- Venue
- Frontiers in Bioengineering and Biotechnology
- Publisher
- Frontiers Media SA
- Published
- 2021-05-13
- Volume
- 9
- Pages
- 664188-664188
- ISSN
- 2296-4185 (ISSN-L)
- OpenAlex
- W3163713485
- Cited by
- 161
- References
- 7
- FWCI
- 7.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 3D Bioprinting of Vascularized Tissues for in vitro and in vivo Applications. https://app.cochat.ai/papers/10.3389/fbioe.2021.664188
- The paper
- Chen, E. P., Toksoy, Z., Davis, B. A., & Geibel, J. P. (2021). 3D Bioprinting of Vascularized Tissues for in vitro and in vivo Applications. Frontiers in Bioengineering and Biotechnology. https://doi.org/10.3389/fbioe.2021.664188
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.